•
Sep 30, 2020

Celanese Q3 2020 Earnings Report

Reported strong demand recovery driven by volume increase and strategic actions.

Key Takeaways

Celanese Corporation reported a strong third quarter with net sales of $1.4 billion, driven by a 20 percent volume recovery. The company achieved GAAP diluted earnings per share of $1.76 and adjusted earnings per share of $1.95. Operating cash flow was $431 million, and free cash flow reached $351 million.

Completed the sale of the 45 percent equity investment in the Polyplastics joint venture to Daicel for approximately $1.6 billion.

Repurchased $111 million in shares in the third quarter and expects to complete an additional $400 million in share repurchases during the fourth quarter.

Launched BlueRidgeâ„¢ cellulosic pellets as an alternative for conventional plastics in single-use consumer applications.

All production facilities across the globe are again fully staffed and operating to meet demand.

Total Revenue
$1.41B
Previous year: $1.59B
-11.0%
EPS
$1.95
Previous year: $2.53
-22.9%
Gross Profit
$327M
Previous year: $414M
-21.0%
Cash and Equivalents
$615M
Previous year: $497M
+23.7%
Free Cash Flow
$351M
Previous year: $315M
+11.4%
Total Assets
$9.77B
Previous year: $9.41B
+3.8%

Celanese

Celanese

Celanese Revenue by Segment

Forward Guidance

The company expects full year 2020 adjusted earnings of approximately $7.00 to $7.10 per share. Looking to 2021, the company remains confident that underlying demand will reach pre-COVID levels at some point in the year.

Positive Outlook

  • Global demand during the third quarter progressed well along the path of recovery.
  • October and November order books are shaping consistently with the third quarter and show no indications of demand retraction.
  • Expects continued momentum in the fourth quarter.
  • Focused on controllable actions to drive strong growth next year, including productivity, production planning, and disciplined capital deployment.
  • Underlying demand will reach pre-COVID levels at some point in the year.

Challenges Ahead

  • Monitoring the current resurgence of COVID-19 across various locations for any impact to our businesses.
  • Various sequential headwinds including normal December seasonality.
  • Major turnaround at our Frankfurt POM facility.
  • Uncertainty remains.
  • Unable to reconcile forecasted adjusted earnings per share growth to US GAAP diluted earnings per share without unreasonable efforts because a forecast of Certain Items, such as mark-to-market pension gains/losses, is not practical.

Revenue & Expenses

Visualization of income flow from segment revenue to net income